FARALLON CAPITAL MANAGEMENT LLC - Q3 2017 holdings

$11.3 Billion is the total value of FARALLON CAPITAL MANAGEMENT LLC's 85 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 0.0% .

 Value Shares↓ Weighting
PLYA  PLAYA HOTELS & RESORTS NV$319,230,000
-12.7%
30,606,9300.0%2.84%
-25.3%
 HERBALIFE LTDnote 2.000% 8/1$108,286,000
-3.9%
108,177,0000.0%0.96%
-17.8%
ANTM  ANTHEM INC$39,875,000
+0.9%
210,0000.0%0.35%
-13.7%
SLD  SUTHERLAND ASSET MGMT CORP M$36,491,000
+5.7%
2,324,2360.0%0.32%
-9.5%
SVRA  SAVARA INC$20,804,000
+59.0%
2,225,0000.0%0.18%
+36.0%
AKBA  AKEBIA THERAPEUTICS INC$14,359,000
+36.9%
730,0000.0%0.13%
+17.4%
WGL  WGL HLDGS INC$10,104,000
+0.9%
120,0000.0%0.09%
-13.5%
PCO  PENDRELL CORPcl a new$5,608,000
-5.5%
821,0610.0%0.05%
-19.4%
QCOM  QUALCOMM INC$4,406,000
-6.1%
85,0000.0%0.04%
-20.4%
BKD  BROOKDALE SR LIVING INC$3,498,000
-27.9%
330,0000.0%0.03%
-38.0%
GCVRZ  SANOFIright 12/31/2020$2,458,000
-5.3%
6,827,8050.0%0.02%
-18.5%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MICROSOFT CORP41Q3 20233.7%
RADIUS HEALTH INC33Q2 20221.7%
GRIFOLS S A33Q4 20210.9%
ALPHABET INC32Q3 20234.2%
SPDR S&P 500 ETF TR31Q3 202325.3%
VISA INC30Q3 20232.9%
WABTEC CORP27Q3 20233.6%
EXELIXIS INC27Q3 20232.8%
ELEVANCE HEALTH INC26Q3 20232.6%
SAVARA INC26Q3 20230.3%

View FARALLON CAPITAL MANAGEMENT LLC's complete holdings history.

Latest significant ownerships (13-D/G)
FARALLON CAPITAL MANAGEMENT LLC Q3 2017 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Atento S.A.March 15, 20232,230,35715.4%
Metals Acquisition CorpFebruary 07, 20232,489,7009.4%
Inflection Point Acquisition Corp.February 06, 20231,900,0005.8%
AMYRIS, INC.February 24, 20221,068,9040.3%
Swiftmerge Acquisition Corp.February 14, 2022291,0601.3%
Caribou Biosciences, Inc.February 11, 20222,428,1504.0%
ENANTA PHARMACEUTICALS INCFebruary 11, 2022287,0001.4%
Protagonist Therapeutics, IncFebruary 11, 2022387,0510.8%
Solid Power, Inc.February 11, 2022? ?
Better Therapeutics, Inc.February 09, 2022124,0650.5%

View FARALLON CAPITAL MANAGEMENT LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR/A2024-05-15
13F-HR/A2024-05-15
13F-HR2024-05-15
13F-HR/A2024-02-14
13F-HR/A2024-02-14
13F-HR/A2024-02-14
13F-HR/A2024-02-14
13F-HR/A2024-02-14
13F-HR/A2024-02-14
13F-HR2024-02-14

View FARALLON CAPITAL MANAGEMENT LLC's complete filings history.

Compare quarters

Export FARALLON CAPITAL MANAGEMENT LLC's holdings